Hologic, Inc. (HOLX) Competitors & Peers
The 5 largest companies in the same industry as Hologic, Inc., by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| ISRG | Peer | $405.18 | P/E 46.5RSI 65Cap 145.2 B |
| MDLN | Peer | $34.70 | P/E 43.4RSI 52Cap 30.4 B |
| BDX | Competitor | $183.82 | P/E 31.9RSI 55Cap 50.1 B |
| ALC | Peer | $64.47 | P/E 49.2RSI 31Cap 31.2 B |
| RMD | Peer | $222.00 | P/E 21.3RSI 46Cap 32.0 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- ENDOMAGMerger
Hologic acquired Endomagnetics Ltd (Endomag) in July 2024 for $310 million to integrate its magnetic breast cancer localization markers (Magseed) and lymphatic tracers (Magtrace) into its Breast Health division.
Model-inferred, unverified — treat as a lead, not evidence - ENDOMAGPartner
Hologic acquired Endomagnetics Ltd (Endomag) in July 2024 for $310 million to integrate its magnetic breast cancer localization markers (Magseed) and lymphatic tracers (Magtrace) into its Breast Health division.
Model-inferred, unverified — treat as a lead, not evidence - DGXPartner
Quest Diagnostics utilizes Hologic's ThinPrep liquid-based cytology systems and Aptima molecular assays under a long-term strategic women's health testing alliance.
Model-inferred, unverified — treat as a lead, not evidence - SHS.DECompetitor
Siemens Healthineers' Mammomat mammography systems compete directly with Hologic's digital breast tomosynthesis systems in clinical imaging centers.
Model-inferred, unverified — treat as a lead, not evidence - GEHCCompetitor
GE HealthCare's Senographe mammography platforms compete directly with Hologic's Genius 3D Mammography systems in the global breast imaging market.
Model-inferred, unverified — treat as a lead, not evidence - LHCustomer
Labcorp is a major diagnostic laboratory customer that runs high volumes of Hologic's Aptima HPV, STI, and diagnostic assays on Panther analyzer platforms.
Model-inferred, unverified — treat as a lead, not evidence - BDXCompetitor
BD's Viper and BD Max molecular testing systems compete directly with Hologic's Panther platform and Aptima assay families in clinical laboratories.
Model-inferred, unverified — treat as a lead, not evidence - SBS.DESupplier
STRATEC manufactures Panther molecular diagnostics platform for Hologic.
Model-inferred, unverified — treat as a lead, not evidence - SBS.DEManufacturer
STRATEC manufactures the core instrument platform powering Hologic's Panther molecular diagnostics system under an exclusive OEM agreement.
Model-inferred, unverified — treat as a lead, not evidence - SBS.DECustomer
Hologic is a primary customer of STRATEC for the Panther molecular diagnostics instrument platform, representing a key revenue concentration.
Model-inferred, unverified — treat as a lead, not evidence